Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07012694
NA

22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions

Sponsor: Huazhong University of Science and Technology

View on ClinicalTrials.gov

Summary

The investigators conduct a prospective, multicenter, blinded, randomized controlled trial to compare the diagnostic value and safety of the 22G Adapt needle versus the 22G Franseen needle for histopathological evaluation of solid lesions.

Official title: A Prospective, Multicenter, Blinded, Randomized Controlled Trial Assessing the Diagnostic Yield and Tissue Adequacy of 22G Adapt Versus 22G Franseen Fine-Needle Biopsy for Solid Lesions Under Endoscopic Ultrasound Guidance

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

576

Start Date

2025-07

Completion Date

2026-12-10

Last Updated

2025-07-01

Healthy Volunteers

No

Interventions

DEVICE

22G Franseen Needle Group

Fine-needle-biopsy (22G Franseen, Boston Scientific, Winston-Salem, USA)

DEVICE

22G Adapt Needle Group

Fine-needle-biopsy (22G Adapt, Micro.Tech Endoscopy, Nanjing, China)

Locations (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China